Kolon Life Science (XKRX:102940) Ending Cash Position : ₩25,564 Mil (As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Kolon Life Science Ending Cash Position?

Kolon Life Science's Ending Cash Position for the quarter that ended in Jun. 2024 was ₩25,564 Mil.

Kolon Life Science's quarterly Ending Cash Position increased from Dec. 2023 (₩7,561 Mil) to Mar. 2024 (₩8,387 Mil) and increased from Mar. 2024 (₩8,387 Mil) to Jun. 2024 (₩25,564 Mil).

Kolon Life Science's annual Ending Cash Position declined from Dec. 2021 (₩27,800 Mil) to Dec. 2022 (₩6,371 Mil) but then increased from Dec. 2022 (₩6,371 Mil) to Dec. 2023 (₩7,561 Mil).

Kolon Life Science Ending Cash Position Historical Data

The historical data trend for Kolon Life Science's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kolon Life Science Ending Cash Position Chart

Kolon Life Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

5,913.52

15,000.81

27,800.29

6,371.34

7,561.34

Kolon Life Science Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Ending Cash Position	Get a 7-Day Free Trial															26,046.15	11,412.64	7,561.34	8,386.71	25,563.58

Kolon Life Science Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Kolon Life Science's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6371.342	+	1190.001
	=	7,561

Kolon Life Science's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	8386.709	+	17176.872
	=	25,564

Kolon Life Science Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Kolon Life Science's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kolon Life Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kolon Life Science Inc (XKRX:102940) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

110, Magokdong-ro, Gangseo-gu, One & Only Tower, Seoul, KOR

Website

http://www.kolonls.co.kr

Kolon Life Science Inc develops, manufactures and sells Biopharmaceuticals, Active pharmaceutical ingredients, Antimicrobials and Water solutions. Its products include Invossa, KLS-1010, KLS-2020, Azilsartan, Besfloc etc. The company has manufacturing facilities in Chungju, Eumsung and Kimchun.

Kolon Life Science Headlines

No Headlines